Who has been buying Kyungnam Pharmaceutical stock?

1 distinct insiders have filed 3 disclosed insider purchases in Kyungnam Pharmaceutical (053950), most recently on 2026-07-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Kyungnam Pharmaceutical have?

Kyungnam Pharmaceutical has 3 buy-side and 0 sell-side disclosures on record, covering ₩10.2B ($7.1M) in total reported value, spanning 2024-02-13 to 2026-07-02.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Kyungnam Pharmaceutical 053950

Company

경남제약Kyungnam Pharmaceutical

Insiders

Buys

Total Value

₩10.2B ($7.1M)

Avg Return

-28.86%

Last Filing

2026-07-02

Kyungnam Pharmaceutical (053950) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩10.2B ($7.1M) in reported transaction value. The earliest filing StockDrifts holds for Kyungnam Pharmaceutical is dated 2024-02-13; the most recent is 2026-07-02. Across these filings the average return since disclosure is -28.86%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-07-02	BUY	제3자배정유상증자	엑스 X	-	4.0M	₩1,640	-6.0%	₩6.5B ($4.5M)
2026-04-16	SELL	주식병합	빌리언스 Billions	-	-11.2M	₩769	+0.0%	₩8.6B ($6.0M)
2024-11-05	BUY	Market Buy	미니쉬테크놀로지 Minish Technology	-	6.6M	₩951	-35.1%	₩6.2B ($4.3M)
2024-11-04	BUY	Market Buy	미니쉬테크놀로지 Minish Technology	-	1.0M	₩785	-21.4%	₩821M ($570K)
2024-11-01	BUY	Market Buy	미니쉬테크놀로지 Minish Technology	-	3.6M	₩882	-30.1%	₩3.2B ($2.2M)
2024-10-23	BUY	유상신주취득	빌리언스 Billions	-	6.9M	₩662	-6.8%	₩4.6B ($3.2M)
2024-10-23	SELL	기타	빌리언스 Billions	-	-6.9M	₩662	+6.8%	₩4.6B ($3.2M)
2024-10-23	BUY	유상신주취득	미니쉬테크놀로지 Minish Technology	-	3.0M	₩662	-6.8%	₩2.0B ($1.4M)
2024-09-12	BUY	기타	빌리언스 Billions	-	6.9M	₩810	-23.8%	₩5.6B ($3.9M)
2024-05-17	SELL	장외매도	스페이셜인베스트먼트 Spatial Investment	-	-3.4M	₩964	+36.0%	₩3.3B ($2.3M)
2024-05-10	BUY	행사가액조정	스페이셜인베스트먼트 Spatial Investment	-	283.5K	₩832	-25.8%	₩236M ($164K)
2024-04-11	SELL	행사가액조정	스페이셜인베스트먼트 Spatial Investment	-	-242.3K	₩828	+25.5%	₩201M ($139K)
2024-03-11	BUY	행사가액조정	스페이셜인베스트먼트 Spatial Investment	-	232.9K	₩828	-25.5%	₩193M ($134K)
2024-02-13	BUY	행사가액조정	스페이셜인베스트먼트 Spatial Investment	-	535.8K	₩896	-31.1%	₩480M ($333K)

Frequently asked questions

Who has been buying Kyungnam Pharmaceutical stock?: 1 distinct insiders have filed 3 disclosed insider purchases in Kyungnam Pharmaceutical (053950), most recently on 2026-07-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kyungnam Pharmaceutical have?: Kyungnam Pharmaceutical has 3 buy-side and 0 sell-side disclosures on record, covering ₩10.2B ($7.1M) in total reported value, spanning 2024-02-13 to 2026-07-02.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.